Cost-effectiveness of Transplanting HCV-Infected Livers into Uninfected Recipients with Preemptive Antiviral Therapy

BACKGROUND & AIMS: Guidelines do not recommend transplanting hepatitis C virus (HCV)-infected livers into HCV-uninfected recipients. Direct-acting antivirals (DAAs) can be used to treat donor-derived HCV infection. However the added cost of DAA therapy is a barrier. We evaluated the cost effecti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Gastroenterol Hepatol
Huvudupphovsmän: Bethea, Emily D., Samur, Sumeyye, Kanwal, Fasiha, Ayer, Turgay, Hur, Chin, Roberts, Mark S., Terrault, Norah, Chung, Raymond T., Chhatwal, Jagpreet
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382534/
https://ncbi.nlm.nih.gov/pubmed/30138735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2018.08.042
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk